Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT05654415

Melatonin vs Sleep Deprivation for Nap EEG

Conditions: Epilepsy

Sex: All
Ages: 4 Years – 10 Years
Phase: NA
Enrollment: 30
Sponsor: IRCCS National Neurological Institute "C. Mondino" Foundation

Location: Italy

Summary

In the pediatric population, electroencephalographic (EEG) recordings are frequently performed in sleep, as it reduces the amount of artifacts and might activate epileptiform discharges. To date, no agreed-upon guidelines are available for hypno-induction for EEG recordings . Among the strategies used, the most commonly used are sleep deprivation, either total or partial, and the use of melatonin, alone or in combination. The investigators proposed a study aiming at evaluating the efficacy of a melatonin-based solution for sleep induction during EEG video recording VS sleep deprivation.In a randomized, crossover study, 30 pediatric patients (aged 4-10 years) will be subjected to two EEG recordings: in one they will receive the melatonin solution (5 mg), in the other they undergo only partial sleep deprivation (about 50% of physiological sleep). The primary endpoint of the study is represented by the time to fall asleep, secondary objectives are represented by frequency of epileptiform discharges, presence/absence of epileptic seizures, In addition, the levels of 6-sulfatoxymelatonina, the primary metabolite of melatonin in saliva and urine, will be determined with a validated LC-MS method.

Eligibility Criteria

Inclusion Criteria:pediatric patients with epilepsy aged between 4 and 10 years with normal psychomotor development and IQ> 70;stable seizure frequency in the 3 months preceding the enrollment ;stable anti-seizure medications in the 3 months preceding the enrollment;written informed consent from the legal representative.Exclusion Criteria:subjects diagnosed with obstructive sleep apnea or other sleep disorders;history of neurodevelopmental disorders;concomitant use of hypnotics, stimulants, systemic corticosteroids or other immunosuppressants;concomitant daily use of melatonin;any conditions which, in the investigator's judgment, would compromise the achievement of the study objectives;refusal to sign the informed consent from the legal representative.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05654415). StuddyBuddy aggregates publicly available trial information.